Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;135(3):206-211.
doi: 10.1017/S0022215121000220. Epub 2021 Jan 18.

Otorhinolaryngological manifestations of coronavirus disease 2019: a prospective review of 600 patients

S Bhatta  1 , S Gandhi  1 , S J Saindani  1 , D Ganesuni  1 , A D Ghanpur  1
Affiliations

Otorhinolaryngological manifestations of coronavirus disease 2019: a prospective review of 600 patients

S Bhatta et al. J Laryngol Otol. 2021 Mar.

Abstract

Objectives: To evaluate otorhinolaryngological manifestations of coronavirus disease 2019 infection and the time required for their resolution.

Methods: A prospective analysis was conducted of coronavirus disease 2019 patients presenting from 1 April 2020 to 30 July 2020. The otorhinolaryngological manifestations were evaluated based on patient history. The time required for symptom resolution was evaluated separately for intensive care unit and non-intensive care unit patients.

Results: A total of 600 patients were included in the study; 13.3 per cent required the intensive care unit and 2.2 per cent expired. The otorhinolaryngological manifestations were: sore throat (88 per cent), fever (78.8 per cent), anosmia or hyposmia (63.6 per cent), ageusia or hypogeusia (63.5 per cent), rhinorrhoea (51.3 per cent), nasal obstruction (33.5 per cent), sneezing (30.3 per cent), and breathing difficulty (18.6 per cent). The time required for symptom resolution was longest for breathing difficulty (23.6 days for intensive care unit and 8.2 days for non-intensive care unit patients).

Conclusion: Otorhinolaryngological symptoms are one of the main presentations of coronavirus disease 2019 infection. The increased prevalence of medical co-morbidities in patients requiring intensive care unit and in deceased patients is also highlighted.

Keywords: COVID-19; Comorbidity; Prospective Studies.

PubMed Disclaimer

Conflict of interest statement

None declared

Figures

Fig. 1.
Fig. 1.
Distribution of patients based on clinical manifestations.
Fig. 2.
Fig. 2.
Time since symptom onset (with respective standard deviations).
Fig. 3.
Fig. 3.
Time needed for symptom resolution (along with standard deviations), both for intensive care unit (ICU) and non-intensive care unit patients.
Fig. 4.
Fig. 4.
Distribution of patients according to medical co-morbidities. COPD = chronic obstructive pulmonary disease; CVD = cardiovascular disease
See this image and copyright information in PMC

References

    1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 1885;91:157–60 - PMC - PubMed
    1. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017–32 - PMC - PubMed
    1. Gengler I, Wang JC, Speth MM, Sedaghat AR. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: a systematic review of the current evidence. Laryngoscope Investig Otolaryngol 2020;5:354–9 - PMC - PubMed
    1. Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis. Travel Med Infect Dis 2020;36:101606. - PMC - PubMed
    1. Wang M, Wu Q, Xu W, Qiao B, Wang J, Zheng H et al.. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv 2020;2020.02.12.20022327

MeSH terms